BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38910012)

  • 1. Heart Failure after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Agassi A; Johnson DY; Ronald J
    J Vasc Interv Radiol; 2024 Jul; 35(7):1090-1091. PubMed ID: 38910012
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal Hypertension after Portal Vein Reconstruction-Transjugular Intrahepatic Portosystemic Shunt Creation Due to Iatrogenic Splenic Arteriovenous Shunt.
    Dalla S; Salem R; Kim SK; Sauk S
    J Vasc Interv Radiol; 2024 Jan; 35(1):158-159. PubMed ID: 38161065
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic encephalopathy and survival after transjugular intrahepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?
    Zhang F; Zhang M; Wang L; Zhuge Y
    J Hepatol; 2024 Jun; 80(6):e260-e261. PubMed ID: 38154742
    [No Abstract]   [Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A; Bureau C; Thabut D; Rudler M
    United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension due to idiopathic myelofibrosis.
    Doki N; Irisawa H; Takada S; Sakura T; Miyawaki S
    Intern Med; 2007; 46(4):187-90. PubMed ID: 17301514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors.
    Modha K; Kapoor B; Lopez R; Sands MJ; Carey W
    Cardiovasc Intervent Radiol; 2018 Apr; 41(4):564-571. PubMed ID: 29181605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
    He FL; Wang L; Yue ZD; Zhao HW; Liu FQ
    World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Intravascular US-Guided Portal Vein Access during Transjugular Intrahepatic Portosystemic Shunt Creation: Retrospective Comparison with Conventional Technique in 109 Patients.
    Pillai AK; Andring B; Faulconer N; Reis SP; Xi Y; Iyamu I; Suthpin PD; Kalva SP
    J Vasc Interv Radiol; 2016 Aug; 27(8):1154-9. PubMed ID: 27363298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.
    Liu K; Fan XX; Wang XL; He CS; Wu XJ
    World J Gastroenterol; 2012 Dec; 18(48):7405-8. PubMed ID: 23326153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension-Induced Refractory Ascites Due to Metastatic Carcinomatous Liver Disease.
    Geeroms B; De Hertogh G; Vanslembrouck R; Wildiers H; Nevens F; Maleux G
    J Vasc Interv Radiol; 2018 Dec; 29(12):1713-1716. PubMed ID: 30392802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal anatomic variants relevant to transjugular intrahepatic portosystemic shunt.
    Saad N; Darcy M; Saad W
    Tech Vasc Interv Radiol; 2008 Dec; 11(4):203-7. PubMed ID: 19527845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise placement of a transjugular intrahepatic portosystemic shunt endograft.
    Clark TW
    Tech Vasc Interv Radiol; 2008 Dec; 11(4):208-11. PubMed ID: 19527846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.
    Jin YN; Zhang W
    World J Gastroenterol; 2024 Apr; 30(16):2285-2286. PubMed ID: 38690019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsuccessful transjugular intrahepatic portosystemic shunt for a patient with right heart failure and portal hypertension.
    Graus L; Verresen L; De Vusser P; Verbrugge FH; Caenepeel P
    Acta Gastroenterol Belg; 2017; 80(1):63-66. PubMed ID: 29364100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular Intrahepatic Portosystemic Shunt Creation in Children Weighing <10 kg Using an Unconventional Technique.
    Sanín E; Suárez-Galvis M; Álvarez S; Santamaría A
    J Vasc Interv Radiol; 2023 Jun; 34(6):1070-1074. PubMed ID: 36764445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transjugular intrahepatic portosystemic shunt in treatment of portal hypertension].
    Tarazov PG
    Khirurgiia (Mosk); 1999; (7):64-9. PubMed ID: 10459195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.